verified SJR 0,943 · Q1 • database Scopus / SJR & Web of Science indexed

Germany · Georg Thieme Verlag

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Pharmacopsychiatry

Pharmacopsychiatry is a journal indexed in SJR in Medicine (miscellaneous) and Psychiatry and Mental Health with an H index of 86. It has a price of 2417 €. It has an SJR impact factor of 0,943 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,943.

ISSN: 0176-3679

Publisher: Georg Thieme Verlag

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,943 Q1

H-index 86

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.417 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,943

H-index

Docs (year)

Docs 3y

103

Total refs

1734

Cites 3y

311

Citable 3y

Cites/Doc 2y

Ref/Doc

48.17

Immediate OA

2417 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Akathisia Masked by Hypokinesia

Valproate and the symptomatic treatment of schizophrenia spectrum patients

Cyclandelate in the Treatment of Patients with Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Vascular Dementia: Experience from a Placebo Controlled Multi-center Study

Critical evaluation of the effect of valerian extract on sleep structure and sleep quality - Pharmacopsychiatry 2000; 33: 47 - 53, by F. Donath et al -

Cost-Benefit Analysis of Newer versus Older Antidepressants - Pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants -

Clozapine-induced Agranulocytosis and Hereditary Polymorphisms of Clozapine Metabolizing Enzymes: No Association with Myeloperoxidase and Cytochrome P4502D6

Citalopram: an Interaction Study with Clomipramine in a Patient Heterozygous for CYP2D6 Genotype

Benzodiazepine Withdrawal - Induced Catatonia

Batch-to-Batch Reproducibility of St. John's Wort Preparations

Atypical Antipsychotics in Bipolar and Schizoaffective Disorders

Association of Paroxetine with Suicide Attempt in Obsessive-Compulsive Disorder

Are Low Basal Serum Levels of the Thyroid Stimulating Hormone (b-TSH) a Risk Factor for Switches into States of Expansive Syndromes (Known in Germany as Maniform Syndromes" in Bipolar I Depression?

SHOW MORE ARTICLES

Antipsychotic Treatment of Schizophrenics at Risk for Violence

A Case of Pharmacokinetic Interference in Comedication of Clozapine and Valproic Acid

Adjunctive Dopamine Agonists in Treatment-Resistant Bipolar II Depression: an Open Case Series

Acute Stress Induced Modifications of Calcium Signaling in Learned Helpless Rats

Acute Effects of Cholecystokinin Tetrapeptide on Brain Stem Auditory Evoked Potentials in Healthy Volunteers

Acute Delusional Parasitosis under Treatment with Ciprofloxacin

Acceptance of Pharmacotherapy for Relapse Prevention by Chronic Alcoholics

A Qualitative Assessment of the Neurological Safety of Antipsychotic Drugs; an Analysis of a Risperidone Database

A Prospective PMS Study to Validate the Sensitivity for Change of the D-Scale in Advanced Stages of Dementia Using the NMDA-Antagonist Memantine

A Prospective Naturalistic Study of 326 Panic-Agoraphobic Patients Treated with Antidepressants

A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients

A Comparison of the Effects of Clozapine and Olanzapine on the EEG in Patients with Schizophrenia

FAQs

Pharmacopsychiatry has an SJR of 0,943 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2417 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Pharmacopsychiatry is 26%.

Pharmacopsychiatry

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Pharmacopsychiatry?

What is the APC / publication cost?

What is the acceptance rate?